Statistics for Cytokinetics (id:7428 CYTK)

Valuation metrics

Market cap

5.79B

Enterprise value

5.52B

Trailing P/E (ttm)

-9.01

Forward P/E

-9.11

PEG ratio

-9.11

Price/Sales (ttm)

1.80K

Price/Book (mrq)

-415.38

Enterprise Value/Revenue

1.72K

Enterprise Value/EBITDA

-10.80

Overview

Shares outstanding

118.01M

Float

117.41M

Shares short

15.69M

% Held by insiders

0.00%

% Held by institutions

1.18%

Average volume (10 days)

1.50M

Average volume (90 days)

Price summary

52-Week low

30.68

52-Week high

110.25

52-Week change

35.17%

Beta

0.78

50-Day moving average

53.74

200-Day moving average

59.53

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

June 25th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-4,284.10%

Operating margin

-30,410.58%

Operational effectiveness

Return on assets

-30.13%

Return on equity

136.22%

Income statement

Revenue (ttm)

0.03

Revenue per share (ttm)

0.03

Quarterly revenue growth (yoy)

Gross profit (ttm)

-322,593,000.00

EBITDA

-511,143,008.00

Net income to common (ttm)

-576,401,984.00

Diluted EPS (ttm)

-5.38

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.01B

Total cash per share (mrq)

8.57

Total debt (mrq)

908.23M

Total Debt/Equity (mrq)

-65.29

Current ratio (mrq)

927.60%

Book value per share (mrq)

-0.12

Cash flow

Cash flow statement

-404,356,992.00

Levered free cash flow (LFCF)

-242,420,992.00